P2X7 Receptor Antagonists Market

P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.
P2X7 Receptor Antagonists Market contains market size and forecasts of P2X7 Receptor Antagonists in Global, including the following market information:
Global P2X7 Receptor Antagonists Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global P2X7 Receptor Antagonists market was valued at 56 million in 2021 and is projected to reach US$ 108.6 million by 2028, at a CAGR of 10.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
GSK1482160 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of P2X7 Receptor Antagonists include GlaxoSmithKline, AstraZeneca, Janssen, RaQualia Pharma, Evotec, Asahi Kasei Pharma and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the P2X7 Receptor Antagonists companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global P2X7 Receptor Antagonists Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global P2X7 Receptor Antagonists Market Segment Percentages, by Type, 2021 (%)
GSK1482160
AZD9056
EVT 401
JNJ 55308942 & JNJ 54175446
AKP-23494954/RQ-00466479
Others
Global P2X7 Receptor Antagonists Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global P2X7 Receptor Antagonists Market Segment Percentages, by Application, 2021 (%)
Inflammatory Diseases
Central Nervous System Diseases
Immune System Disorders
Global P2X7 Receptor Antagonists Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global P2X7 Receptor Antagonists Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies P2X7 Receptor Antagonists revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies P2X7 Receptor Antagonists revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
AstraZeneca
Janssen
RaQualia Pharma
Evotec
Asahi Kasei Pharma
Pfizer